The global Podophyllin market was valued at approximately USD 1 million in 2023. As the need for effective treatments for HPV-related diseases and cancer continues to grow, this market is projected to reach USD 1.19 million by 2030, exhibiting a compound annual growth rate (CAGR) of 2.50% from 2024 to 2030. This growth trajectory highlights the expanding demand for Podophyllin-based products, driven by medical advancements and increasing healthcare access across regions.
read more..